← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Novozymes
Healthcare & biotech / Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebEnterprise Value
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Stock Price | Number Of Shares | Market Capitalization | Minus Cash And Cash Equivalents | Add Total Debt | Enterprise Value |
---|---|---|---|---|---|---|
2024-12 | 407.24 | 277.9 | 113174.94 | 280.0 | 1796.8 | 114691.74 |
2023-12 | 370.75 | 277.94 | 103048.56 | 1116.0 | 7733.0 | 109665.56 |
2022-12 | 350.45 | 276.64 | 96950.71 | 1041.0 | 411.0 | 96320.71 |
2021-12 | 543.37 | 277.91 | 151014.89 | 963.0 | 482.0 | 150533.89 |
Wait! There's more — sign up for free or log in